skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Suppressive effects of lysozyme on polyphosphate-mediated vascular inflammatory responses

Journal Article · · Biochemical and Biophysical Research Communications
 [1];  [2];  [1];  [1]
  1. College of Pharmacy, CMRI, Research Institute of Pharmaceutical Sciences, BK21 Plus KNU Multi-Omics Based Creative Drug Research Team, Kyungpook National University, Daegu 41566 (Korea, Republic of)
  2. Department of Anatomy and Histology, College of Korean Medicine, Daegu Haany University, Gyeongsan 38610 (Korea, Republic of)

Lysozyme, found in relatively high concentration in blood, saliva, tears, and milk, protects us from the ever-present danger of bacterial infection. Previous studies have reported proinflammatory responses of endothelial cells to the release of polyphosphate(PolyP). In this study, we examined the anti-inflammatory responses and mechanisms of lysozyme and its effects on PolyP-induced septic activities in human umbilical vein endothelial cells (HUVECs) and mice. The survival rates, septic biomarker levels, behavior of human neutrophils, and vascular permeability were determined in PolyP-activated HUVECs and mice. Lysozyme suppressed the PolyP-mediated vascular barrier permeability, upregulation of inflammatory biomarkers, adhesion/migration of leukocytes, and activation and/or production of nuclear factor-κB, tumor necrosis factor-α, and interleukin-6. Furthermore, lysozyme demonstrated protective effects on PolyP-mediated lethal death and the levels of the related septic biomarkers. Therefore, these results indicated the therapeutic potential of lysozyme on various systemic inflammatory diseases, such as sepsis or septic shock. -- Highlights: •PolyP is shown to be an important mediator of vascular inflammation. •Lysozyme inhibited PolyP-mediated hyperpermeability. •Lysozyme inhibited PolyP-mediated septic response. •Lysozyme reduced PolyP-induced septic mortality.

OSTI ID:
22598767
Journal Information:
Biochemical and Biophysical Research Communications, Vol. 474, Issue 4; Other Information: Copyright (c) 2016 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.; Country of input: International Atomic Energy Agency (IAEA); ISSN 0006-291X
Country of Publication:
United States
Language:
English

Similar Records

Barrier protective effects of withaferin A in HMGB1-induced inflammatory responses in both cellular and animal models
Journal Article · Sun Jul 01 00:00:00 EDT 2012 · Toxicology and Applied Pharmacology · OSTI ID:22598767

Anti-inflammatory effects of methylthiouracil in vitro and in vivo
Journal Article · Sun Nov 01 00:00:00 EDT 2015 · Toxicology and Applied Pharmacology · OSTI ID:22598767

Zingerone reduces HMGB1-mediated septic responses and improves survival in septic mice
Journal Article · Tue Aug 15 00:00:00 EDT 2017 · Toxicology and Applied Pharmacology · OSTI ID:22598767